Replies to post #164856 on Biotech Values

[jbog]

I'd be careful not to underestimate Teva's marketing prowlness in the MS market.

[genisi]

CEO also said Teva will continue to detail regular Copaxone even if they get FDA approval for the thrice-weekly product. This is new information.

That CEO is gone and if the new one is thinking what FRX' was thinking...

Forest Laboratories Announces Intention to Continue Marketing Both NAMENDA® TABLETS and Once-Daily NAMENDA XR® Into the Fall of 2014

https://finance.yahoo.com/news/forest-laboratories-announces-intention-continue-200100630.html